The shareholders of Zelluna consist of a consortium of life science investors.

Zelluna’s Investors have extensive experience in developing biotech companies from early initiation of cutting edge technologies to excellent businesses, especially within the field of oncology. The consortium will take an active role in the long-term strategic development of Zelluna.